Richard E. Kast
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, HER2/EGFR in Cancer Research, Cancer, Stress, Anesthesia, and Immune Response, Radiopharmaceutical Chemistry and Applications, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Bupropion: pharmacology and therapeutic applications(2006)346 cited
- → A new chapter opens in anti-inflammatory treatments:The antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice(2006)195 cited
- → A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care(2013)165 cited
- → Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomide(2012)139 cited
- → CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide(2014)117 cited
- → Lithium and hematology: established and proposed uses(2008)94 cited
- → The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?(2019)68 cited
- → A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3(2021)65 cited
- → Anti- and pro-inflammatory considerations in antidepressant use during medical illness: bupropion lowers and mirtazapine increases circulating tumor necrosis factor-alpha levels(2003)63 cited
- → Tumor necrosis factor has positive and negative self regulatory feed back cycles centered around cAMP(2000)62 cited